Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Apr 30

PMID 33915810

Citations 6

Authors

Paul B Romesser

Neelam Tyagi

Christopher H Crane

Affiliations

Soon will be listed here.

Abstract

Technological advances have enabled well tolerated and effective radiation treatment for small liver metastases. Stereotactic ablative radiation therapy (SABR) refers to ablative dose delivery (>100 Gy BED) in five fractions or fewer. For larger tumors, the safe delivery of SABR can be challenging due to a more limited volume of healthy normal liver parenchyma and the proximity of the tumor to radiosensitive organs such as the stomach, duodenum, and large intestine. In addition to stereotactic treatment delivery, controlling respiratory motion, the use of image guidance, adaptive planning and increasing the number of radiation fractions are sometimes necessary for the safe delivery of SABR in these situations. Magnetic Resonance (MR) image-guided adaptive radiation therapy (MRgART) is a new and rapidly evolving treatment paradigm. MR imaging before, during and after treatment delivery facilitates direct visualization of both the tumor target and the adjacent normal healthy organs as well as potential intrafraction motion. Real time MR imaging facilitates non-invasive tumor tracking and treatment gating. While daily adaptive re-planning permits treatment plans to be adjusted based on the anatomy of the day. MRgART therapy is a promising radiation technology advance that can overcome many of the challenges of liver SABR and may facilitate the safe tumor dose escalation of colorectal liver metastases.

Citing Articles

Deep Learning Framework with Multi-Head Dilated Encoders for Enhanced Segmentation of Cervical Cancer on Multiparametric Magnetic Resonance Imaging.

Kalantar R, Curcean S, Winfield J, Lin G, Messiou C, Blackledge M Diagnostics (Basel). 2023; 13(21).

PMID: 37958277 PMC: 10647438. DOI: 10.3390/diagnostics13213381.

Evaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radiotherapy.

Chick J, Alexander S, Herbert T, Huddart R, Ingle M, Mitchell A Phys Imaging Radiat Oncol. 2023; 27:100481.

PMID: 37655122 PMC: 10465927. DOI: 10.1016/j.phro.2023.100481.

The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer.

Kalaei Z, Manafi-Farid R, Rashidi B, Kiani F, Zarei A, Fathi M Cell Commun Signal. 2023; 21(1):139.

PMID: 37316886 PMC: 10265921. DOI: 10.1186/s12964-023-01151-y.

MRI-LINAC: A transformative technology in radiation oncology.

Ng J, Gregucci F, Pennell R, Nagar H, Golden E, Knisely J Front Oncol. 2023; 13:1117874.

PMID: 36776309 PMC: 9911688. DOI: 10.3389/fonc.2023.1117874.

Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers.

Hauth F, Roberts H, Hong T, Duda D Int J Mol Sci. 2022; 23(4).

PMID: 35216045 PMC: 8879105. DOI: 10.3390/ijms23041926.

References

Blomgren H, Lax I, Naslund I, Svanstrom R . Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995; 34(6):861-70. DOI: 10.3109/02841869509127197. View

Pan C, Kavanagh B, Dawson L, Li X, Das S, Miften M . Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S94-100. PMC: 4388033. DOI: 10.1016/j.ijrobp.2009.06.092. View

Romesser P, Neal B, Crane C . External Beam Radiation Therapy for Liver Metastases. Surg Oncol Clin N Am. 2020; 30(1):159-173. DOI: 10.1016/j.soc.2020.08.006. View

Shah S, Haddad R, Al-Sukhni W, Kim R, Greig P, Grant D . Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg. 2006; 202(3):468-75. DOI: 10.1016/j.jamcollsurg.2005.11.008. View

Johnson B, Jin Z, Truty M, Smoot R, Nagorney D, Kendrick M . Impact of Metastasectomy in the Multimodality Approach for V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience. Oncologist. 2017; 23(1):128-134. PMC: 5759813. DOI: 10.1634/theoncologist.2017-0230. View

Onaitis M, Petersen R, Haney J, Saltz L, Park B, Flores R . Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg. 2009; 87(6):1684-8. DOI: 10.1016/j.athoracsur.2009.03.034. View

Lehnert T, Knaebel H, Duck M, Bulzebruck H, Herfarth C . Sequential hepatic and pulmonary resections for metastatic colorectal cancer. Br J Surg. 1999; 86(2):241-3. DOI: 10.1046/j.1365-2168.1999.01010.x. View

Briere T, Beddar S, Balter P, Murthy R, Gupta S, Nelson C . Respiratory gating with EPID-based verification: the MDACC experience. Phys Med Biol. 2009; 54(11):3379-91. DOI: 10.1088/0031-9155/54/11/007. View

Heinzerling J, Anderson J, Papiez L, Boike T, Chien S, Zhang G . Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys. 2008; 70(5):1571-8. DOI: 10.1016/j.ijrobp.2007.12.023. View

10.

Hall W, Straza M, Chen X, Mickevicius N, Erickson B, Schultz C . Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. PLoS One. 2020; 15(8):e0236570. PMC: 7413561. DOI: 10.1371/journal.pone.0236570. View

11.

Lewis S, Porceddu S, Nakamura N, Palma D, Lo S, Hoskin P . Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. Am J Clin Oncol. 2015; 40(4):418-422. DOI: 10.1097/COC.0000000000000169. View

12.

Scorsetti M, Comito T, Tozzi A, Navarria P, Fogliata A, Clerici E . Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer. J Cancer Res Clin Oncol. 2014; 141(3):543-53. DOI: 10.1007/s00432-014-1833-x. View

13.

Wurm R, Gum F, Erbel S, Schlenger L, Scheffler D, Agaoglu D . Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol. 2006; 45(7):881-9. DOI: 10.1080/02841860600919233. View

14.

Fiz F, Vigano L, Gennaro N, Costa G, Bella L, Boichuk A . Radiomics of Liver Metastases: A Systematic Review. Cancers (Basel). 2020; 12(10). PMC: 7600822. DOI: 10.3390/cancers12102881. View

15.

Liang S, Zhu X, Xu Z, Zhu J, Zhao J, Lu H . Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys. 2006; 65(2):426-34. DOI: 10.1016/j.ijrobp.2005.12.031. View

16.

Dawson L, McGinn C, Normolle D, Ten Haken R, Walker S, Ensminger W . Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2000; 18(11):2210-8. DOI: 10.1200/JCO.2000.18.11.2210. View

17.

Okumura T, Boku N, Hishida T, Ohde Y, Sakao Y, Yoshiya K . Surgical Outcome and Prognostic Stratification for Pulmonary Metastasis From Colorectal Cancer. Ann Thorac Surg. 2017; 104(3):979-987. DOI: 10.1016/j.athoracsur.2017.03.021. View

18.

Yang J, Cai J, Wang H, Chang Z, Czito B, Bashir M . Is diaphragm motion a good surrogate for liver tumor motion?. Int J Radiat Oncol Biol Phys. 2014; 90(4):952-8. PMC: 4334361. DOI: 10.1016/j.ijrobp.2014.07.028. View

19.

Garcea G, Lloyd T, Aylott C, Maddern G, Berry D . The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer. 2003; 39(15):2150-64. DOI: 10.1016/s0959-8049(03)00553-7. View

20.

Dawson L, Normolle D, Balter J, McGinn C, Lawrence T, Ten Haken R . Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002; 53(4):810-21. DOI: 10.1016/s0360-3016(02)02846-8. View